Several recent publications have suggested that TNF-i also has a beneficial impact on CVR.20, 21, 22 In a meta-analysis, Westlake et al. summarized the potential effects of anti-TNF-α in patients with psoriatic arthritis on major adverse cardiovascular events (MACE) and on the risk of developing cardiovascular disease again. This evidence concerns the gene TNF and psoriatic arthritis.